Skip to main content
Clinical Trials/JPRN-UMIN000024302
JPRN-UMIN000024302
Recruiting
未知

Analysis of circulating tumor cells(CTCs) and clinical significance of CTCs; human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trial - Analysis of circulating tumor cells in the clinical study of ANP administration for lung cancer surgery (JANP study) (Subanalysis of JANP study)

Osaka University Graduate School of Medicine0 sites500 target enrollmentOctober 19, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
non-small cell lung cancer
Sponsor
Osaka University Graduate School of Medicine
Enrollment
500
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Thin\-section CT fulfills the proportion of maximum diameter of the tumor itself to consolidation is less than 0\.25\. 2\. Patient with active the other concurrent malignant diseases. 3\. Women during pregnancy or breast\-feeding. 4\. Psychosis. 5\. Systemic steroids or immunosuppressive agents medication. 6\. Uncontrollable infectious disease, autoimmune disease, or the other severe comorbidities. 7\. History of right ventricular infarction. 8\. Severe hypotension 9\. Other conditions judged ineligible by physician

Outcomes

Primary Outcomes

Not specified

Similar Trials